BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, July 27, 2024
See today's BioWorld
Home
» Regulatory actions for Jan. 10, 2024
To read the full story,
subscribe
or
sign in
.
Regulatory actions for Jan. 10, 2024
Jan. 10, 2024
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbisko, Astellas, Biogen, Corbus, Focal Medical, GC Cell, Genmab, Mediwound, Novelmed, Nuvation, Pfizer, Sellas, Seres, Shorla Oncology, Skye, Vertex.
BioWorld
Briefs
Regulatory actions